top of page

Product Pipeline

The Manzanita product pipeline is divided into two parts: 

  • Nerve imaging agents (dye-neurotrophins) - $9.3 Billion
     

  • Novel drug candidates (small molecule drug-neurotrophins) - $42.2 Billion

Nervelight.jpeg
PipelineTable.png
bottom of page